Clinical efficacy of Guben Fangxiao decoction in children with syndrome of qi deficiency of lung and spleen during remission of asthma: a report of 30 cases

Objective: To observe the clinical efficacy of Guben Fangxiao decoction in children with syndrome of qi deficiency of lung and spleen during remission of asthma. Methods: Sixty children in remission of asthma were randomly divided into treatment group( n = 30) and control group( n = 30). The treatment group received Guben Fangxiao decoction,while the control group received Seretide. Results: After treatment,the treatment group showed significant improvements in score of traditional Chinese medicine symptoms,number of asthma attacks,upper respiratory tract infections,pulmonary ventilation function,and childhood asthma control test( C- ACT) score( P 0. 05); there were no significant differences in C- ACT score,number of asthma attacks,and pulmonary ventilation function between the two groups( P 0. 05),but significant difference was found in number of upper respiratory tract infections( P 0. 05). Conclusion: Guben Fangxiao decoction can be used as a choice of treatment in children with syndrome of qi deficiency of lung and spleen during remission of asthma.